United States · FDA National Drug Code directory

Daptomycin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43598-476_29677998-337b-a026-92f5-1a3958dec926
Product NDC
43598-476
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Composition / generic term
Daptomycin
Labeler
Dr. Reddy's Laboratories Inc.,
Marketing category
ANDA
Marketing start / end (source format)
20211004
Source listing expiry
20261231

Source-listed ingredients

  • DAPTOMYCIN — 350 mg/7mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-476-11) / 7 mL in 1 VIAL, SINGLE-DOSE · 43598-476-11
  • 10 VIAL, SINGLE-DOSE in 1 CARTON (43598-476-58) / 7 mL in 1 VIAL, SINGLE-DOSE · 43598-476-58

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Daptomycin — United States | Molindra Medicines